Press Releases :: IceCure Medical Ltd. (ICCM)

Skip to main content Skip to section navigation Skip to footer

May 15, 2023 8:00 am EDT

IceCure to Report First Quarter 2023 Financial & Operational Results on

May 01, 2023 8:00 am EDT

Cryoablation Takes Center Stage at American Society of Breast Surgeons' 24th Annual Meeting

Apr 24, 2023 8:00 am EDT

IceCure Medical to Provide Educational Support in a First-of-its-Kind Cryotherapy Course at the American Society of Breast Surgeons' 24th Annual Meeting

Apr 20, 2023 8:00 am EDT

IceCure's ProSense System Used in Endometriosis Cryoablation Study That Demonstrated Efficacy Rate of 92.8% to Avoid Secondary Surgery

Apr 19, 2023 8:00 am EDT

IceCure Medical Ordinary Shares to Trade Exclusively on Nasdaq: Company to Voluntarily Delist Shares from Trading on the Tel Aviv Stock Exchange

Mar 29, 2023 8:00 am EDT

IceCure Medical Reports 2022 Full Year Financial Results & Recent Corporate Developments; Milestone Achievements Expected to Drive Revenue Growth in 2023

Mar 28, 2023 8:00 am EDT

IceCure Medical Receives Regulatory Approval in China for Commercial Use of its IceSense3 Disposable Cryoprobes

Mar 20, 2023 8:00 am EDT

IceCure Medical to Report 2022 Full Year Financial & Operational Results on March 29, 2023

Feb 09, 2023 8:00 am EST

IceCure Medical Announces Preliminary Unaudited 2022 Year-End Financial Results & Recent Operational Highlights

Jan 26, 2023 8:00 am EST

IceCure's ProSense Featured in Breast Session at the Society of Interventional Oncology's Annual Scientific Meeting in Washington, D.C.

Select a page:

rss_feed News RSS

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

© 2025 All Rights Reserved IceCure Medical

Branding by

Terms of Use | Privacy | Last Updated: April 9, 2023